Document is current
Any future updates will be listed below
-
Authors
Ferretti, Maria Teresa https://orcid.org/0000-0003-0459-9615
Uccheddu, Maria Bonaria https://orcid.org/0009-0007-8188-8310
Flanagan, Richelle
Leroi, Iracema https://orcid.org/0000-0003-1822-3643
Moro, Elena https://orcid.org/0000-0002-7968-5908
- License Information
-
More Information
Article History
Accepted: 26 November 2024
First Online: 7 January 2025
Competing interests
: M.T.F. is the co-founder of the Women’s Brain Project. In the past 2 years she has received consulting and speaking fees from Roche, Angelini Pharma and Prodeco Pharma unrelated to this project. She is currently the Clinical Development Lead of Syntropic Medical. M.U. has received honoraria for consulting services from Alexion, Janssen, Merck, UCB Pharma and UCB S.A., and speaking fees from Alexion and UCB S.A.. She also provided consulting services to Argenx. Travel expenses for congresses were paid by Alexion, UCB Pharma, UCB S.A. and Argenx. R.F. is the co-founder and chief executive officer of My Moves Matter. E.M. has received restricted research grant support from Abbott and France Parkinson. She has also received honoraria from Medtronic for consultation services. I.L. declares advisory boards and honoraria for talks from Roche, NovoNordisk, Eli Lilly and Boehringer.
